Jaideep Puri, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 221 Greenwich Cir, Suite 110, Jupiter, FL 33458 Phone: 561-694-1021 Fax: 561-694-1908 |
Aleksandar Milovanovic, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 210 Jupiter Lakes Blvd Ste 4202, Jupiter, FL 33458 Phone: 561-660-1642 Fax: 855-346-3285 |
James P Mullen, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4425 Military Trl, Suite 212, Jupiter, FL 33458 Phone: 561-721-1112 Fax: 561-296-3082 |
Dr. Israel Louis Wacks, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 210 Jupiter Lakes Blvd, Ste 5201, Jupiter, FL 33458 Phone: 561-743-2450 |
Abbas Rabiei, Md, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 641 University Blvd, Suite 211, Jupiter, FL 33458 Phone: 561-253-8121 Fax: 561-253-8021 |
Imtiaz Matin Ather, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4425 Military Trl Ste 212, Jupiter, FL 33458 Phone: 561-721-1112 Fax: 561-296-3082 |
David S Amrose, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4425 Military Trl, Suite 4425, Jupiter, FL 33458 Phone: 561-721-1112 Fax: 561-296-3082 |
Monique N Pratt, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4425 Military Trl, Suite 212, Jupiter, FL 33458 Phone: 561-721-1112 |
News Archive
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
Rexahn Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering.
Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.
People carrying the germ-line MSH6 mutation are at high risk by age 80 years for colorectal and endometrial cancers and any cancer associated with Lynch syndrome, according to a new study published online December 22 in the Journal of the National Cancer Institute.
› Verified 5 days ago